These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36189478)

  • 21. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.
    Agrawal AM; Dudhedia MS; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):133-47. PubMed ID: 26729533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions.
    Ojo AT; Lee PI
    J Pharm Sci; 2021 Apr; 110(4):1495-1512. PubMed ID: 32818440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.
    Saboo S; Kestur US; Flaherty DP; Taylor LS
    Mol Pharm; 2020 Apr; 17(4):1261-1275. PubMed ID: 32134677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
    Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
    Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QbD approach to downstream processing of spray-dried amorphous solid dispersions - a case study.
    Henriques J; Moreira J; Doktorovová S
    Pharm Dev Technol; 2021 Mar; 26(3):269-277. PubMed ID: 33322990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of incorporated drugs on material properties of amorphous solid dispersions.
    Flügel K; Schmidt K; Mareczek L; Gäbe M; Hennig R; Thommes M
    Eur J Pharm Biopharm; 2021 Feb; 159():88-98. PubMed ID: 33383170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lacidipine Amorphous Solid Dispersion Based on Hot Melt Extrusion: Good Miscibility, Enhanced Dissolution, and Favorable Stability.
    Xi L; Song H; Wang Y; Gao H; Fu Q
    AAPS PharmSciTech; 2018 Oct; 19(7):3076-3084. PubMed ID: 30094722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2012 Jan; 101(1):342-53. PubMed ID: 21935949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.
    Lin X; Hu Y; Liu L; Su L; Li N; Yu J; Tang B; Yang Z
    Pharm Res; 2018 Apr; 35(6):125. PubMed ID: 29687226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical stability and solubility of the thermotropic mesophase of fenoprofen calcium as pure drug and in a tablet formulation.
    Patterson J; Bary A; Rades T
    Int J Pharm; 2002 Oct; 247(1-2):147-57. PubMed ID: 12429493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput kinetic turbidity analysis for determination of amorphous solubility and excipient screening for amorphous solid dispersions.
    Fan Y; Castleberry S
    Int J Pharm; 2023 Jan; 631():122495. PubMed ID: 36526147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.
    Hanada M; Jermain SV; Thompson SA; Furuta H; Fukuda M; Williams RO
    Mol Pharm; 2021 Jan; 18(1):198-213. PubMed ID: 33291881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid state properties and drug release behavior of co-amorphous indomethacin-arginine tablets coated with Kollicoat® Protect.
    Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2017 Oct; 119():150-160. PubMed ID: 28602869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
    Luebbert C; Wessner M; Sadowski G
    Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of co-administered stabilizers on the biopharmaceutical performance of regorafenib amorphous solid dispersions.
    Müller M; Wiedey R; Hoheisel W; Serno P; Breitkreutz J
    Eur J Pharm Biopharm; 2021 Dec; 169():189-199. PubMed ID: 34756974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Hot-Melt Extrusion Processing Conditions on Physicochemical Properties of Amorphous Solid Dispersions Containing Thermally Labile Acrylic Copolymer.
    Mathers A; Hassouna F; Malinová L; Merna J; Růžička K; Fulem M
    J Pharm Sci; 2020 Feb; 109(2):1008-1019. PubMed ID: 31605688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Glass Forming Ability on the Physical Stability of Supersaturated Amorphous Solid Dispersions.
    Blaabjerg LI; Bulduk B; Lindenberg E; Löbmann K; Rades T; Grohganz H
    J Pharm Sci; 2019 Aug; 108(8):2561-2569. PubMed ID: 30878513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Amorphous Solid Dispersions and Identification of Low Levels of Crystallinity by Transmission Electron Microscopy.
    S'ari M; Blade H; Cosgrove S; Drummond-Brydson R; Hondow N; Hughes LP; Brown A
    Mol Pharm; 2021 May; 18(5):1905-1919. PubMed ID: 33797925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
    Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.